Gemcitabine in the treatment of advanced pancreatic cancer: A comparative analysis of randomized trials

被引：73

作者：

Heinemann, V ^{[1
]}

机构：

[1] Univ Munich, Klinikum Grosshadern, Dept Hematol Oncol, D-81377 Munich, Germany

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37372

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9 / 16

页数：8

共 31 条

[11]

COPUR SM, 2001, P AN M AM SOC CLIN, V20, pA619

[12]

DICOSTANZO F, 2001, P AN M AM SOC CLIN, V20, pA612

[13] Gemcitabine-based combination treatment of pancreatic cancer [J].

Heinemann, V .

SEMINARS IN ONCOLOGY, 2002, 29 (01) :25-35

[14] Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer [J].

Heinemann, V ;

Wilke, H ;

Mergenthaler, HG ;

Clemens, M ;

König, H ;

Illiger, HJ ;

Arning, M ;

Schalhorn, A ;

Possinger, K ;

Fink, U .

ANNALS OF ONCOLOGY, 2000, 11 (11) :1399-1403

[15]

HEINEMANN V, 2001, P AN M AM SOC CLIN, V20, pA625

[16]

HERRMANN R, 2000, P AN M AM SOC CLIN, V19, pA1038

[17]

Karasek P, 2000, ANN ONCOL, V11, P66

[18]

Kindler H., 2001, European Journal of Cancer, V37, pS311, DOI 10.1016/S0959-8049(01)81643-9

[19] Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer [J].

Lima, CMSR ;

Savarese, D ;

Bruckner, H ;

Dudek, A ;

Eckardt, J ;

Hainsworth, J ;

Yunus, F ;

Lester, E ;

Miller, W ;

Saville, W ;

Elfring, GL ;

Locker, PK ;

Compton, LD ;

Miller, LL ;

Green, MR .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1182-1191

[20] Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma:: Final results of a GERCOR multicenter phase II study [J].

Louvet, C ;

André, T ;

Lledo, G ;

Hammel, P ;

Bleiberg, H ;

Bouleuc, C ;

Gamelin, E ;

Flesch, M ;

Cvitkovic, E ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1512-1518

← 1 2 3 4 →